ITTN – Director
With more than 15 years' experience in technology transfer, Tamar boasts a successful track record of bringing medical innovations from the lab to the marketplace. Tamar is the CEO of Hadasit, chair of Hadasit Bio Holdings (HBL, TASE: HDST) and a board member of Kahr Medical. Prior to joining Hadasit, Tamar served as VP of Marketing and Strategy at Ramot, the technology transfer company of Tel Aviv University, responsible for the company strategic alliances, marketing activities and commercialization. Tamar was the founder and CEO of Allergene Ltd., an Israeli drug development start-up company. Tamar received her MSc and PhD in cell biology from the Tel Aviv University School of Medicine.